HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshio Ando Selected Research

Immunoglobulin G (IgG)

1/2020Capturing transient antibody conformations with DNA origami epitopes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshio Ando Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 01/2017
2COVID-19
09/2023 - 01/2023
2Congenital Abnormalities (Deformity)
01/2023 - 01/2022
2Human Influenza (Influenza)
01/2020 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
04/2019 - 10/2010
1Stroke (Strokes)
01/2021
1Muscular Diseases (Myopathy)
01/2021
1Colonic Neoplasms (Colon Cancer)
10/2020
1Influenza in Birds (Avian Flu)
01/2020
1Rupture
01/2020
1Infections
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2010
1Tetraploidy
02/2005

Drug/Important Bio-Agent (IBA)

2Amyloid (Amyloid Fibrils)IBA
09/2023 - 04/2019
2Proteins (Proteins, Gene)FDA Link
01/2023 - 10/2010
2Islet Amyloid PolypeptideIBA
01/2022 - 04/2019
2Virulence Factors (Pathogenicity Factors)IBA
01/2020 - 01/2020
2Hemagglutinins (Hemagglutinin)IBA
01/2020 - 01/2020
1polyglutamineIBA
01/2023
1Neutralizing AntibodiesIBA
01/2023
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2022
1Myosin SubfragmentsIBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1Myosin Type IIIBA
01/2021
11,2-cyclohexanediolIBA
10/2020
1Peptides (Polypeptides)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1BuffersIBA
01/2020
1MLN 8237IBA
01/2017
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2017
1Collagenases (Collagenase)FDA Link
01/2016
1CollagenIBA
01/2016
1LithostathineIBA
10/2010
1DNA (Deoxyribonucleic Acid)IBA
02/2005

Therapy/Procedure

1Immunotherapy
01/2020